Table 4.
H-FABP levels in relation to cardiovascular events in patients with different glucose metabolism status
| Glucose metabolism status | HRs (95% CIs) | |||
|---|---|---|---|---|
| Unadjusted | p value | Adjusteda | p value | |
| NGR | ||||
| Tertile 1 | Reference | – | Reference | – |
| Tertile 2 | 2.101 (0.998–4.215) | 0.053 | 2.016 (0.994–4.088) | 0.052 |
| Tertile 3 | 1.563 (0.713–3.427) | 0.265 | 1.347 (0.611–2.967) | 0.460 |
| Pre-DM | ||||
| Tertile 1 | 1.303 (0.696–2.477) | 0.418 | 1.211 (0.635–2.439) | 0.448 |
| Tertile 2 | 1.498 (0.802–2.796) | 0.205 | 1.395 (0.748–2.579) | 0.312 |
| Tertile 3 | 2.382 (1.295–4.382) | 0.005 | 1.855 (1.076–3.214) | 0.033 |
| DM | ||||
| Tertile 1 | 2.590 (1.413–4.746) | 0.002 | 2.131 (1.157–3.925) | 0.015 |
| Tertile 2 | 2.755 (1.511–5.023) | 0.001 | 2.171 (1.179–3.997) | 0.013 |
| Tertile 3 | 3.529 (1.976–6.302) | < 0.001 | 2.560 (1.409–4.650) | 0.002 |
Italic values indicate statistical significance
NGR normal glucose regulation, Pre-DM pre-diabetes mellitus, DM diabetes mellitus, H-FABP heart-type fatty acid-binding protein, HRs hazard ratios, CIs confidential intervals
aAdjusted for age, gender, hypertension, dyslipidemia, body mass index, current smoking, family history of CAD and Gensini score, eGFR